MedPath

Role of Priclinical and clinical study NIA/KC/2022/01 In The Management of Vyanabala Vaishmya (Essential Hypertention)

Phase 2
Conditions
Health Condition 1: R030- Elevated blood-pressure reading, without diagnosis of hypertension
Registration Number
CTRI/2022/09/045652
Lead Sponsor
ational Institute of Ayurveda and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients willing to sign the consent form for the clinical trial.

2.Patients belonging to either sex between the age group 18 to 59 years.

3.Patients having no known complication of disease.

4.Diagnosed case of stage-1E.H.T would be selected for study (as per JNC.)

Exclusion Criteria

1. 1.Patients below age of 18 years and above 59 years.

2. Patients having secondary hypertension.

3. Patents having systemic / serious complications of Cardiovascular / Cerebrovascular / Renal System.

4. Pregnant patients.

5. Patients on Oral Contraceptive Pills.

6. History of liver disease in the recent past.

7. Hypertension- Retinopathy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in Systolic and Diastolic blood pressersTimepoint: 16 months
Secondary Outcome Measures
NameTimeMethod
Reduction in Subjective parameters of Essential HypertensionTimepoint: 12 months
© Copyright 2025. All Rights Reserved by MedPath